Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 174

The DOI matches its Crossref record.

Supplemental Breast MRI for Women with Extremely Dense Breasts: Results of the Second Screening Round of the DENSE Trial

Open access
Veenhuizen, Stefanie G. A., de Lange, Stéphanie V., Bakker, Marije F., Pijnappel, Ruud M., Mann, Ritse M., Monninkhof, Evelyn M., Emaus, Marleen J., de Koekkoek-Doll, Petra K., Bisschops, Robertus H. C., Lobbes, Marc B. I., de Jong, Mathijn D. F., Duvivier, Katya M., Veltman, Jeroen, Karssemeijer, Nico, de Koning, Harry J., van Diest, Paul J., Mali, Willem P. T. M., van den Bosch, Maurice A. A. J., van Gils, Carla H., Veldhuis, Wouter B., For the DENSE Trial Study Group, van Gils, C. H., Bakker, M. F., de Lange, S. V., Veenhuizen, S. G. A., Veldhuis, W. B., Pijnappel, R. M., Emaus, M. J., Peeters, P. H. M., Monninkhof, E. M., Fernandez-Gallardo, M. A., Mali, W. P. T. M., van den Bosch, M. A. A. J., van Diest, P. J., Mann, R. M., Mus, R., Imhof-Tas, M., Karssemeijer, N., Loo, C. E., de Koekkoek-Doll, P. K., Winter-Warnars, H. A. O., Bisschops, R. H. C., Kock, M. C. J. M., Storm, R. K., van der Valk, P. H. M., Lobbes, M. B. I., Gommers, S., Lobbes, M. B. I., de Jong, M. D. F., Rutten, M. J. C. M., Duvivier, K. M., de Graaf, P., Veltman, J., Bourez, R. L. J. H., de Koning, H. J. · 2021 · Radiology

Abstract

Background In the first (prevalent) supplemental MRI screening round of the Dense Tissue and Early Breast Neoplasm Screening (DENSE) trial, a considerable number of breast cancers were found at the cost of an increased false-positive rate (FPR). In incident screening rounds, a lower cancer detection rate (CDR) is expected due to a smaller pool of prevalent cancers, and a reduced FPR, due to the availability of prior MRI examinations. Purpose To investigate screening performance indicators of the second round (incidence round) of the DENSE trial. Materials and Methods The DENSE trial (ClinicalTrials.gov: NCT01315015) is embedded within the Dutch population–based biennial mammography screening program for women aged 50–75 years. MRI examinations were performed between December 2011 and January 2016. Women were eligible for the second round when they again had a negative screening mammogram 2 years after their first MRI. The recall rate, biopsy rate, CDR, FPR, positive predictive values, and distributions of tumor characteristics were calculated and compared with results of the first round using 95% CIs and χ2 tests. Results A total of 3436 women (median age, 56 years; interquartile range, 48–64 years) underwent a second MRI screening. The CDR was 5.8 per 1000 screening examinations (95% CI: 3.8, 9.0) compared with 16.5 per 1000 screening examinations (95% CI: 13.3, 20.5) in the first round. The FPR was 26.3 per 1000 screening examinations (95% CI: 21.5, 32.3) in the second round versus 79.8 per 1000 screening examinations (95% CI: 72.4, 87.9) in the first round. The positive predictive value for recall was 18% (20 of 110 participants recalled; 95% CI: 12.1, 26.4), and the positive predictive value for biopsy was 24% (20 of 84 participants who underwent biopsy; 95% CI: 16.0, 33.9), both comparable to that of the first round. All tumors in the second round were stage 0–I and node negative. Conclusion The incremental cancer detection rate in the second round was 5.8 per 1000 screening examinations—compared with 16.5 per 1000 screening examinations in the first round. This was accompanied by a strong reduction in the number of false-positive results. © RSNA, 2021 Online supplemental material is available for this article. See also the editorial by Moy and Gao in this issue.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1148/radiol.2021203633

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 174

Metadata

Authors
Veenhuizen, S. G. A., de Lange, S. V., Bakker, M. F., Pijnappel, R. M., Mann, R. M., Monninkhof, E. M., Emaus, M. J., de Koekkoek-Doll, P. K., Bisschops, R. H. C., Lobbes, M. B. I., de Jong, M. D. F., Duvivier, K. M., Veltman, J., Karssemeijer, N., de Koning, H. J., van Diest, P. J., Mali, W. P. T. M., van den Bosch, M. A. A. J., van Gils, C. H., Veldhuis, W. B., For the DENSE Trial Study Group, van Gils, C. H., Bakker, M. F., de Lange, S. V., Veenhuizen, S. G. A., Veldhuis, W. B., Pijnappel, R. M., Emaus, M. J., Peeters, P. H. M., Monninkhof, E. M., Fernandez-Gallardo, M. A., Mali, W. P. T. M., van den Bosch, M. A. A. J., van Diest, P. J., Mann, R. M., Mus, R., Imhof-Tas, M., Karssemeijer, N., Loo, C. E., de Koekkoek-Doll, P. K., Winter-Warnars, H. A. O., Bisschops, R. H. C., Kock, M. C. J. M., Storm, R. K., van der Valk, P. H. M., Lobbes, M. B. I., Gommers, S., Lobbes, M. B. I., de Jong, M. D. F., Rutten, M. J. C. M., Duvivier, K. M., de Graaf, P., Veltman, J., Bourez, R. L. J. H., & de Koning, H. J.
Venue
Radiology
Published
2021-05
Volume
299
Issue
2
Pages
278-286
ISSN
  • 0033-8419 (ISSN-L)
  • 1527-1315
OpenAlex
W3137095879
Cited by
174
References
0
Type
supplementary materials
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Supplemental Breast MRI for Women with Extremely Dense Breasts: Results of the Second Screening Round of the DENSE Trial. https://app.cochat.ai/papers/10.1148/radiol.2021203633
The paper
Veenhuizen, S. G. A., de Lange, S. V., Bakker, M. F., Pijnappel, R. M., Mann, R. M., Monninkhof, E. M., Emaus, M. J., de Koekkoek-Doll, P. K., Bisschops, R. H. C., Lobbes, M. B. I., de Jong, M. D. F., Duvivier, K. M., Veltman, J., Karssemeijer, N., de Koning, H. J., van Diest, P. J., Mali, W. P. T. M., van den Bosch, M. A. A. J., van Gils, C. H., . . . de Koning, H. J. (2021). Supplemental Breast MRI for Women with Extremely Dense Breasts: Results of the Second Screening Round of the DENSE Trial. Radiology. https://doi.org/10.1148/radiol.2021203633

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.